Results 11 to 20 of about 5,870,697 (401)

Antibiotic Therapy in Dentistry

International Journal of Dentistry, 2021
Dental caries, pulpal necrosis, trauma, and periodontal diseases can result in dental infections which could have severe consequences that affect both soft and hard tissues of the oral cavity.
Hanie Ahmadi, Alireza Ebrahimi, Fatemeh Ahmadi   +2 more
doaj   +2 more sources

Impact of antibiotic therapy on the development and response to treatment of immune checkpoint inhibitor-mediated diarrhea and colitis

Journal for ImmunoTherapy of Cancer, 2019
Background The gut microbiome impacts the efficacy of immune checkpoint inhibitor (ICI) therapy and the development of ICI-mediated diarrhea and/or colitis (IMDC).
Hamzah Abu-Sbeih, Lauren Nicholas Herrera, Tenglong Tang, Mehmet Altan, Anne-Maria P. Chaftari, Pablo C. Okhuysen, Robert R. Jenq, Yinghong Wang   +7 more
doaj   +2 more sources

Antibiotic-Therapy-Induced Gut Dysbiosis Affecting Gut Microbiota—Brain Axis and Cognition: Restoration by Intake of Probiotics and Synbiotics

International Journal of Molecular Sciences, 2023
Antibiotic therapy through short-term or repeated long-term prescriptions can have several damaging effects on the normal microbiota of the gastrointestinal tract.
Divakar Dahiya, P. Nigam
semanticscholar   +1 more source

Antibiotic Therapy for Prosthetic Joint Infections: An Overview

Antibiotics, 2022
Prosthetic joint infection (PJI) is a severe complication after arthroplasty. Its management combines surgical intervention, whose type depends on the clinical situation, and prolonged high-dose antibiotics adapted to the responsible microorganism(s) and
Benjamin Le Vavasseur, V. Zeller
semanticscholar   +1 more source

Antibiotic Therapy for 6 or 12 Weeks for Prosthetic Joint Infection.

New England Journal of Medicine, 2021
BACKGROUND The management of prosthetic joint infection usually consists of a combination of surgery and antimicrobial therapy. The appropriate duration of antimicrobial therapy for this indication remains unclear.
L. Bernard, C. Arvieux, B. Brunschweiler, S. Touchais, S. Ansart, J. Bru, E. Oziol, C. Boéri, G. Gras, J. Druon, P. Rosset, É. Senneville, H. Bentayeb, D. Bouhour, G. Le Moal, J. Michon, H. Aumaître, E. Forestier, J. Laffosse, T. Bégué, C. Chirouze, F. Dauchy, E. Devaud, B. Martha, D. Burgot, D. Boutoille, E. Stindel, A. Dinh, P. Bémer, B. Giraudeau, B. Issartel, A. Caille   +31 more
semanticscholar   +1 more source

Benefits of Combined Phage–Antibiotic Therapy for the Control of Antibiotic-Resistant Bacteria: A Literature Review

Antibiotics, 2022
With the increase in bacterial resistance to antibiotics, more and more therapeutic failures are being reported worldwide. The market for antibiotics is now broken due to the high cost of developing new molecules.
K. Diallo, A. Dublanchet
semanticscholar   +1 more source

Timing of antibiotic therapy in the ICU

Critical Care, 2021
Severe or life threatening infections are common among patients in the intensive care unit (ICU). Most infections in the ICU are bacterial or fungal in origin and require antimicrobial therapy for clinical resolution.
M. Kollef, A. Shorr, M. Bassetti, J. Timsit, S. Micek, A. Michelson, J. Garnacho-Montero   +6 more
semanticscholar   +1 more source

Biomarker‐Guided Individualization of Antibiotic Therapy

Clinical pharmacology and therapy, 2021
Treatment failure of antibiotic therapy due to insufficient efficacy or occurrence of toxicity is a major clinical challenge, and is expected to become even more urgent with the global rise of antibiotic resistance.
L. Aulin, D. Lange, Mohammed A A Saleh, Piet H. Graaf, S. Völler, J. G. Hasselt   +5 more
semanticscholar   +1 more source

Time to appropriate antibiotic therapy is a predictor of outcome in patients with bloodstream infection caused by KPC-producing Klebsiella pneumoniae

Critical Care, 2020
Bloodstream infections (BSIs) by Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae (Kp) are associated with high mortality.
M. Falcone, M. Bassetti, G. Tiseo, Cesira Giordano, Elia Nencini, A. Russo, E. Graziano, E. Tagliaferri, A. Leonildi, S. Barnini, A. Farcomeni, F. Menichetti   +11 more
semanticscholar   +1 more source

Phage Therapy for Antibiotic-Resistant Bacterial Infections.

Annual Review of Medicine, 2021
Antibiotic resistance in bacterial pathogens presents a substantial threat to the control of infectious diseases. Development of new classes of antibiotics has slowed in recent years due to pressures of cost and market profitability, and there is a ...
G. Hatfull, R. Dedrick, R. Schooley
semanticscholar   +1 more source